These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 37348266)

  • 1. Meloxicam emulgel potently suppressed cartilage degradation in knee osteoarthritis: Optimization, formulation, industrial scalability and pharmacodynamic analysis.
    Jyothi VGS; Veerabomma H; Kumar R; Khatri DK; Singh SB; Madan J
    Colloids Surf B Biointerfaces; 2023 Aug; 228():113399. PubMed ID: 37348266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoemulsion based gel for transdermal delivery of meloxicam: physico-chemical, mechanistic investigation.
    Khurana S; Jain NK; Bedi PM
    Life Sci; 2013 Mar; 92(6-7):383-92. PubMed ID: 23353874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and
    Khan MI; Yaqoob S; Madni A; Akhtar MF; Sohail MF; Saleem A; Tahir N; Khan KU; Qureshi OS
    Biomed Res Int; 2022; 2022():8170318. PubMed ID: 36483631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-articular injection PLGA blends sustained-release microspheres loaded with meloxicam: preparation, optimization, evaluation
    Sun Z; Gu X; Hao T; Liu J; Gao R; Li Y; Yu B; Xu H
    Drug Deliv; 2022 Dec; 29(1):3317-3327. PubMed ID: 36369759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation.
    Shaji J; Menon I
    Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam.
    Khurana S; Jain NK; Bedi PM
    Life Sci; 2013 Nov; 93(21):763-72. PubMed ID: 24113071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation of meloxicam gel for topical application: In vitro and in vivo evaluation.
    Bachhav YG; Patravale VB
    Acta Pharm; 2010 Jun; 60(2):153-63. PubMed ID: 21134852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of co-administration of resveratrol with meloxicam in patients with knee osteoarthritis: a pilot interventional study.
    Hussain SA; Marouf BH; Ali ZS; Ahmmad RS
    Clin Interv Aging; 2018; 13():1621-1630. PubMed ID: 30233159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ion-pair formation combined with a penetration enhancer as a dual strategy to improve the transdermal delivery of meloxicam.
    Jiang Q; Wang J; Ma P; Liu C; Sun M; Sun Y; He Z
    Drug Deliv Transl Res; 2018 Feb; 8(1):64-72. PubMed ID: 29181834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and sub-acute dermal toxicity of meloxicam emulgel: Analysis of biochemical, hematological, histopathological and immunohistochemical expression.
    Jyothi VGSS; Veerabomma H; Tryphena KP; Khatri DK; Singh SB; Madan J
    Biochem Biophys Res Commun; 2023 Jun; 660():88-95. PubMed ID: 37079955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitosan Encapsulated Meloxicam Nanoparticles for Sustained Drug Delivery Applications: Preparation, Characterization, and Pharmacokinetics in Wistar Rats.
    Yegireddy M; Nadoor P; Rao S; Hanumanthu PB; Rajashekaraiah R; Ramachandrappa SC; Halemani GM; Mannem S; Prasad TNVKV; Ubaradka S
    Molecules; 2022 Oct; 27(21):. PubMed ID: 36364138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan Nanoparticles for Meloxicam Ocular Delivery: Development, In Vitro Characterization, and In Vivo Evaluation in a Rabbit Eye Model.
    Mohamed HB; Attia Shafie MA; Mekkawy AI
    Pharmaceutics; 2022 Apr; 14(5):. PubMed ID: 35631479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self nanoemulsifying granules (SNEGs) of meloxicam: preparation, characterization, molecular modeling and evaluation of in vivo anti-inflammatory activity.
    Parekh VJ; Desai ND; Shaikh MS; Shinde UA
    Drug Dev Ind Pharm; 2017 Apr; 43(4):600-610. PubMed ID: 28005437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination anesthetic therapy: co-delivery of ropivacaine and meloxicam using transcriptional transactivator peptide modified nanostructured lipid carriers
    Yuan S; Chen J; Feng S; Li M; Sun Y; Liu Y
    Drug Deliv; 2022 Dec; 29(1):263-269. PubMed ID: 35014916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meloxicam encapsulated nanostructured colloidal self-assembly for evaluating antitumor and anti-inflammatory efficacy in 3D printed scaffolds.
    Rarokar N; C R; Gurav S; Khedekar P
    J Biomed Mater Res A; 2021 Aug; 109(8):1441-1456. PubMed ID: 33289225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, Optimization and Evaluation of Orally Disintegrating Tablet of Meloxicam Using Its Menthol Based Solid Dispersions.
    Dehghani H; Taheri A; Homayouni A
    Curr Drug Deliv; 2017; 14(5):709-717. PubMed ID: 27142108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced transdermal delivery of meloxicam by nanocrystals: Preparation,
    Yu Q; Wu X; Zhu Q; Wu W; Chen Z; Li Y; Lu Y
    Asian J Pharm Sci; 2018 Nov; 13(6):518-526. PubMed ID: 32104426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eplerenone modulates the inflammatory response in monosodium iodoacetate-induced knee osteoarthritis in rats: Involvement of RANKL/OPG axis.
    Mostafa RE; Salama AAA
    Life Sci; 2023 Mar; 316():121405. PubMed ID: 36681186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meloxicam-loaded Phospholipid/solutol® HS15 Based Mixed Nanomicelles: Preparation, Characterization, and in vitro Antioxidant Activity.
    Shaji J; Varkey D
    Pharm Nanotechnol; 2016; 4(3):167-190. PubMed ID: 29052497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dasatinib-Loaded Topical Nano-Emulgel for Rheumatoid Arthritis: Formulation Design and Optimization by QbD, In Vitro, Ex Vivo, and In Vivo Evaluation.
    Donthi MR; Saha RN; Singhvi G; Dubey SK
    Pharmaceutics; 2023 Feb; 15(3):. PubMed ID: 36986597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.